Top news
All coverage
Novo Nordisk’s (NYSE:NVO) Ozempic Linked to Lower Risk of Cancer
By Vince Condarcuri
Diabetes patients on GLP-1 treatments instead of insulin have lower cancer risk, study shows
By Maggie Fick
Popular weight-loss and diabetes medications linked to lower risk of some cancers, study finds
By Deidre McPhillips
Ozempic and other GLP-1 drugs could reduce risk of cancer for diabetes patients, study says
By Bruce Gil
'Skinny jabs' like Wegovy reduce the risk of 10 types of cancer more than other drugs, study says
By Alice Fuller
Yet ANOTHER Ozempic breakthrough: Weight loss jabs could help ward off 10-types of cancer, new study suggests
By Emily Stearn
Ozempic May Cut the Risk of Obesity-Related Cancer
By Egle Kristopaityte
GLP-1s tied to lower risk for 10 types of cancer compared with insulin in type 2 diabetes
By Michael Monostra
Ozempic and similar drugs may lower cancer risks, study finds
By Gabrielle M. Etzel
Drugs Like Ozempic Are Linked to a Lower Cancer Risk
By Naomi Kresge & Madison Muller
Popular weight-loss and diabetes medications linked to lower risk of some cancers, study finds
By Deidre McPhillips